ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NLSP NLS Pharmaceutics Ltd

0.13785
-0.00075 (-0.54%)
Last Updated: 11:08:11
Delayed by 15 minutes

Period:

Draw Mode:

Volume 68,593
Bid Price 0.1327
Ask Price 0.1399
News -
Day High 0.1449

Low
0.113

52 Week Range

High
1.53

Day Low 0.1326
Share Name Share Symbol Market Stock Type
NLS Pharmaceutics Ltd NLSP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.00075 -0.54% 0.13785 11:08:11
Open Price Low Price High Price Close Price Previous Close
0.144 0.1326 0.1449 0.1386
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
47 68,593 US$ 0.1333472 US$ 9,147 - 0.113 - 1.53
Last Trade Type Quantity Price Currency
10:59:59 211 US$ 0.13785 USD

NLS Pharmaceutics Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 4.47M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NLS Pharmaceutics News

Date Time Source News Article
3/11/202415:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/23/202415:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/12/202416:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/29/202315:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/22/202315:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/06/202315:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/04/202315:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/04/202315:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/01/202306:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/16/202315:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202315:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202308:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NLSP Message Board. Create One! See More Posts on NLSP Message Board See More Message Board Posts

Historical NLSP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.13390.14530.130.1375323100,4500.003952.95%
1 Month0.150.1650.1130.1375299182,769-0.01215-8.10%
3 Months0.430.48990.1130.1672681628,788-0.29215-67.94%
6 Months0.650.7270.1130.3646706580,098-0.51215-78.79%
1 Year1.181.530.1130.4802528349,978-1.04-88.32%
3 Years3.393.730.1131.33592,029-3.25-95.93%
5 Years2.99657.350.1132.63788,670-2.86-95.40%

NLS Pharmaceutics Description

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States.

Your Recent History

Delayed Upgrade Clock